{
    "code": "72000019",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=72000019",
    "time": "2020-06-19 03:30:13",
    "許可證字號": "衛部罕菌疫輸字第000019號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/11\/28",
    "發證日期": "106\/11\/28",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA07200001902",
    "中文品名": "保優利63微克筆型注射液",
    "英文品名": "Plegridy 63mcg solution for injection",
    "適應症": "治療復發型-緩解型多發性硬化症。",
    "劑型": "27D注射液劑",
    "包裝": "0.5毫升預充式注射筆 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "基因工程產品_新成分",
    "監視期限": "111\/11\/28",
    "主成分略述": "peginterferon beta-1a",
    "限制項目": "02輸　入 5F免除銜接性試驗",
    "申請商名稱": "0407901100  衛采製藥股份有限公司",
    "申請商地址": "台北市長安東路一段十八號九樓",
    "主製造廠": [
        {
            "製造廠名稱": "FDE0267600  VETTER PHARMA - FERTIGUNG GMBH &amp; CO. KG",
            "製造廠廠址": "SCHUTZENSTRABE 87 AND 99-101 88212 RAVENSBURG, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FDK0047100  BIOGEN DENMARK MANUFACTURING APS",
            "製造廠廠址": "BIOGEN ALLE 1, DK-3400 HILLEROD, DENMARK",
            "製造廠公司地址": "",
            "製造廠國別": "DENMARK",
            "製程": "包裝"
        },
        {
            "製造廠名稱": "FNL0116000  BIOGEN NETHERLANDS B.V.",
            "製造廠廠址": "PRINS MAURITSLAAN 13, 1171 LP BADHOEVEDORP, THE NETHERLANDS",
            "製造廠公司地址": "",
            "製造廠國別": "NETHERLANDS",
            "製程": "許可證持有者"
        },
        {
            "製造廠名稱": "FUS0785000  BIOGEN INC.",
            "製造廠廠址": "5000 DAVIS DRIVE, RESEARCH TRIANGLE PARK, NORTH CAROLINA 27709, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥製造廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0818003010",
            "成分名稱": "peginterferon beta-1a",
            "含量描述": "",
            "含量": "63.0000000000",
            "單位": "MCG"
        }
    ],
    "仿單外盒": [
        {
            "title": "中文PIL_TW-PL-ET-19J-01_20200422_Clean-109-05-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000019&Seq=006&Type=9"
        },
        {
            "title": "中文PI_TW-PL-ET-19J-01_20200422_Clean-109-05-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000019&Seq=005&Type=9"
        },
        {
            "title": "MOCK-UP Plegridy 63_label-109-05-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000019&Seq=006&Type=8"
        },
        {
            "title": "MOCK-UP CARTON_2PK_PLEGRIDY_LIQ_63_94MCG_PF_PEN_STRT_PK_TWN_P3-109-05-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000019&Seq=005&Type=8"
        }
    ]
}